Deciphera Pharmaceuticals, Inc. SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
Deciphera Pharmaceuticals, Inc. had SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount of $31.27 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Notes
us-gaap:ValuationAllowancesAndReservesBalance · last filed 2024-05-10
- 2024-03-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $31.27M.
- 2023-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $27.59M.
- 2023-09-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $27.26M.
- 2023-06-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $24.72M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount |
|---|---|
| 2024-03-31 | $31.27M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $27.59M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $27.26M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $24.72M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $21.85M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $18.33M 10-K · filed 2024-02-07 |
| 2022-09-30 | $13.45M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $12.54M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $10.94M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $9.44M 10-K · filed 2023-02-07 |
| 2021-09-30 | $7.12M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $5.90M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $5.55M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $3.38M 10-K · filed 2022-02-08 |
| 2020-09-30 | $1.60M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $509.00K 10-Q · filed 2020-08-04 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-09 |